P300-dependent STAT3 acetylation is necessary for angiotensin II-induced pro-fibrotic responses in renal tubular epithelial cells

Aim: To explore the role of signal transducer and activator of transcription 3 (STAT3) signaling pathway, especially STAT3 acetylation, in angiotensin II (Ang II)-induced pro-fibrotic responses in renal tubular epithelial cells. Methods: Rat renal tubular epithelial cell line (NRK-52E) was used. STA...

Full description

Saved in:
Bibliographic Details
Published inActa pharmacologica Sinica Vol. 35; no. 9; pp. 1157 - 1166
Main Authors Ni, Jun, Shen, Yang, Wang, Zhen, Shao, De-cui, Liu, Jia, Kong, Ya-li, Fu, Lan-jun, Zhou, Li, Xue, Hong, Huang, Yu, Zhang, Wei, Yu, Chen, Lu, Li-min
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.09.2014
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Aim: To explore the role of signal transducer and activator of transcription 3 (STAT3) signaling pathway, especially STAT3 acetylation, in angiotensin II (Ang II)-induced pro-fibrotic responses in renal tubular epithelial cells. Methods: Rat renal tubular epithelial cell line (NRK-52E) was used. STAT3 acetylation, phosphorylation and Janus kinase 2 (Jak2) phosphorylation, as well as the expression of fibronectin, collagen IV, transforming growth factor-131 (TGF-β1) and p300 were examined using Western blotting. The level and localization of STAT3 phosphorylation on Tyr705 were detected with fluorescence immunocytochemistry. The cells were transfected with a plasmid vector carrying p300 gene or siRNA targeting p300 to regulate p300 expression. Results: Overexpression of p300 significantly increased STAT3 acetylation on Lys685, STAT3 phosphorylation on Tyr705, and the expression of TGF-β1, collagen IV and fibronectin in the cells. Treatment of the cells with Ang II (1 pmol/L) significantly increased STAT3 phosphorylation on Tyr705 through JAK2 activation, and dose-dependently increased the expression of fibronectin, collagen IV and TGF-β1. Pretreatment with curcumin, an inhibitor of JAK2 and p300, blocked Ang II-induced effects. Knockdown of p300 significantly decreased STAT3 acetylation on Lys685, and abolished Ang II-stimulated STAT3 phosphorylation on Tyr705, whereas pretreatment of the cells with C646, a selective inhibitor of p300, inhibited Ang II-induced STAT3 nuclear translocation and the expression of TGF- 131, collagen IV and fibronectin. Pretreatment of the cells with AG490, a JAK2 inhibitor, markedly inhibited Ang II-induced STAT3 phosphorylation on Tyr705 and fibronectin expression. Conclusion: P300-dependent STAT3 acetylation is necessary for Ang II-induced STAT3 phosphorylation and the consequent pro-fibrotic responses in renal tubular epithelial cells in vitro.
AbstractList Aim: To explore the role of signal transducer and activator of transcription 3 (STAT3) signaling pathway, especially STAT3 acetylation, in angiotensin II (Ang II)-induced pro-fibrotic responses in renal tubular epithelial cells. Methods: Rat renal tubular epithelial cell line (NRK-52E) was used. STAT3 acetylation, phosphorylation and Janus kinase 2 (Jak2) phosphorylation, as well as the expression of fibronectin, collagen IV, transforming growth factor-131 (TGF-β1) and p300 were examined using Western blotting. The level and localization of STAT3 phosphorylation on Tyr705 were detected with fluorescence immunocytochemistry. The cells were transfected with a plasmid vector carrying p300 gene or siRNA targeting p300 to regulate p300 expression. Results: Overexpression of p300 significantly increased STAT3 acetylation on Lys685, STAT3 phosphorylation on Tyr705, and the expression of TGF-β1, collagen IV and fibronectin in the cells. Treatment of the cells with Ang II (1 pmol/L) significantly increased STAT3 phosphorylation on Tyr705 through JAK2 activation, and dose-dependently increased the expression of fibronectin, collagen IV and TGF-β1. Pretreatment with curcumin, an inhibitor of JAK2 and p300, blocked Ang II-induced effects. Knockdown of p300 significantly decreased STAT3 acetylation on Lys685, and abolished Ang II-stimulated STAT3 phosphorylation on Tyr705, whereas pretreatment of the cells with C646, a selective inhibitor of p300, inhibited Ang II-induced STAT3 nuclear translocation and the expression of TGF- 131, collagen IV and fibronectin. Pretreatment of the cells with AG490, a JAK2 inhibitor, markedly inhibited Ang II-induced STAT3 phosphorylation on Tyr705 and fibronectin expression. Conclusion: P300-dependent STAT3 acetylation is necessary for Ang II-induced STAT3 phosphorylation and the consequent pro-fibrotic responses in renal tubular epithelial cells in vitro.
To explore the signal transducer and activator of transcription 3 (STAT3) signaling pathway, especially STAT3 acetylation, in angiotensin II (Ang II)-induced pro-fibrotic responses in renal tubular epithelial cells.AIMTo explore the signal transducer and activator of transcription 3 (STAT3) signaling pathway, especially STAT3 acetylation, in angiotensin II (Ang II)-induced pro-fibrotic responses in renal tubular epithelial cells.Rat renal tubular epithelial cell line (NRK-52E) was used. STAT3 acetylation and phosphorylation, as well as the expression of fibronectin, collagen IV and transforming growth factor-β1 (TGF-β1) were examined using Western blotting. The level and localization of STAT3 phosphorylation on Tyr705 were detected with fluorescence immunocytochemistry. The cells were transfected with a plasmid vector carrying p300 gene or siRNA targeting p300 to regulate p300 expression.METHODSRat renal tubular epithelial cell line (NRK-52E) was used. STAT3 acetylation and phosphorylation, as well as the expression of fibronectin, collagen IV and transforming growth factor-β1 (TGF-β1) were examined using Western blotting. The level and localization of STAT3 phosphorylation on Tyr705 were detected with fluorescence immunocytochemistry. The cells were transfected with a plasmid vector carrying p300 gene or siRNA targeting p300 to regulate p300 expression.Overexpression of p300 significantly increased STAT3 acetylation on Lys685, STAT3 phosphorylation on Tyr705, and the expression of TGF-β1, collagen IV and fibronectin in the cells. Treatment of the cells with Ang II (1 μmol/L) significantly increased STAT3 phosphorylation on Tyr705 through JAK2 activation, and dose-dependently increased the expression of fibronectin, collagen IV and TGF-β1. Pretreatment with curcumin, an inhibitor of JAK2 and p300, blocked Ang II-induced effects. Knockdown of p300 significantly decreased STAT3 acetylation on Lys685, and abolished Ang II-stimulated STAT3 phosphorylation on Tyr705, whereas pretreatment of the cells with C646, a selective inhibitor of p300, inhibited Ang II-induced STAT3 nuclear translocation and the expression of TGF-β1, collagen IV and fibronectin. Pretreatment of the cells with AG490, a JAK2 inhibitor, markedly inhibited Ang II-induced STAT3 phosphorylation on Tyr705 and fibronectin expression.RESULTSOverexpression of p300 significantly increased STAT3 acetylation on Lys685, STAT3 phosphorylation on Tyr705, and the expression of TGF-β1, collagen IV and fibronectin in the cells. Treatment of the cells with Ang II (1 μmol/L) significantly increased STAT3 phosphorylation on Tyr705 through JAK2 activation, and dose-dependently increased the expression of fibronectin, collagen IV and TGF-β1. Pretreatment with curcumin, an inhibitor of JAK2 and p300, blocked Ang II-induced effects. Knockdown of p300 significantly decreased STAT3 acetylation on Lys685, and abolished Ang II-stimulated STAT3 phosphorylation on Tyr705, whereas pretreatment of the cells with C646, a selective inhibitor of p300, inhibited Ang II-induced STAT3 nuclear translocation and the expression of TGF-β1, collagen IV and fibronectin. Pretreatment of the cells with AG490, a JAK2 inhibitor, markedly inhibited Ang II-induced STAT3 phosphorylation on Tyr705 and fibronectin expression.p300-dependent STAT3 acetylation is necessary for Ang II-induced STAT3 phosphorylation and the consequent pro-fibrotic responses in renal tubular epithelial cells in vitro.CONCLUSIONp300-dependent STAT3 acetylation is necessary for Ang II-induced STAT3 phosphorylation and the consequent pro-fibrotic responses in renal tubular epithelial cells in vitro.
To explore the signal transducer and activator of transcription 3 (STAT3) signaling pathway, especially STAT3 acetylation, in angiotensin II (Ang II)-induced pro-fibrotic responses in renal tubular epithelial cells. Rat renal tubular epithelial cell line (NRK-52E) was used. STAT3 acetylation and phosphorylation, as well as the expression of fibronectin, collagen IV and transforming growth factor-β1 (TGF-β1) were examined using Western blotting. The level and localization of STAT3 phosphorylation on Tyr705 were detected with fluorescence immunocytochemistry. The cells were transfected with a plasmid vector carrying p300 gene or siRNA targeting p300 to regulate p300 expression. Overexpression of p300 significantly increased STAT3 acetylation on Lys685, STAT3 phosphorylation on Tyr705, and the expression of TGF-β1, collagen IV and fibronectin in the cells. Treatment of the cells with Ang II (1 μmol/L) significantly increased STAT3 phosphorylation on Tyr705 through JAK2 activation, and dose-dependently increased the expression of fibronectin, collagen IV and TGF-β1. Pretreatment with curcumin, an inhibitor of JAK2 and p300, blocked Ang II-induced effects. Knockdown of p300 significantly decreased STAT3 acetylation on Lys685, and abolished Ang II-stimulated STAT3 phosphorylation on Tyr705, whereas pretreatment of the cells with C646, a selective inhibitor of p300, inhibited Ang II-induced STAT3 nuclear translocation and the expression of TGF-β1, collagen IV and fibronectin. Pretreatment of the cells with AG490, a JAK2 inhibitor, markedly inhibited Ang II-induced STAT3 phosphorylation on Tyr705 and fibronectin expression. p300-dependent STAT3 acetylation is necessary for Ang II-induced STAT3 phosphorylation and the consequent pro-fibrotic responses in renal tubular epithelial cells in vitro.
To explore the signal transducer and activator of transcription 3 (STAT3) signaling pathway, especially STAT3 acetylation, in angiotensin II (Ang II)-induced pro-fibrotic responses in renal tubular epithelial cells. Rat renal tubular epithelial cell line (NRK-52E) was used. STAT3 acetylation and phosphorylation, as well as the expression of fibronectin, collagen IV and transforming growth factor-[beta]1 (TGF-[beta]1) were examined using Western blotting. The level and localization of STAT3 phosphorylation on Tyr705 were detected with fluorescence immunocytochemistry. The cells were transfected with a plasmid vector carrying p300 gene or siRNA targeting p300 to regulate p300 expression. Overexpression of p300 significantly increased STAT3 acetylation on Lys685, STAT3 phosphorylation on Tyr705, and the expression of TGF-[beta]1, collagen IV and fibronectin in the cells. Treatment of the cells with Ang II (1 μmol/L) significantly increased STAT3 phosphorylation on Tyr705 through JAK2 activation, and dose-dependently increased the expression of fibronectin, collagen IV and TGF-[beta]1. Pretreatment with curcumin, an inhibitor of JAK2 and p300, blocked Ang II-induced effects. Knockdown of p300 significantly decreased STAT3 acetylation on Lys685, and abolished Ang II-stimulated STAT3 phosphorylation on Tyr705, whereas pretreatment of the cells with C646, a selective inhibitor of p300, inhibited Ang II-induced STAT3 nuclear translocation and the expression of TGF-[beta]1, collagen IV and fibronectin. Pretreatment of the cells with AG490, a JAK2 inhibitor, markedly inhibited Ang II-induced STAT3 phosphorylation on Tyr705 and fibronectin expression. p300-dependent STAT3 acetylation is necessary for Ang II-induced STAT3 phosphorylation and the consequent pro-fibrotic responses in renal tubular epithelial cells in vitro.
Aim: To explore the signal transducer and activator of transcription 3 (STAT3) signaling pathway, especially STAT3 acetylation, in angiotensin II (Ang II)-induced pro-fibrotic responses in renal tubular epithelial cells. Methods: Rat renal tubular epithelial cell line (NRK-52E) was used. STAT3 acetylation and phosphorylation, as well as the expression of fibronectin, collagen IV and transforming growth factor-β1 (TGF-β1) were examined using Western blotting. The level and localization of STAT3 phosphorylation on Tyr705 were detected with fluorescence immunocytochemistry. The cells were transfected with a plasmid vector carrying p300 gene or siRNA targeting p300 to regulate p300 expression. Results: Overexpression of p300 significantly increased STAT3 acetylation on Lys685, STAT3 phosphorylation on Tyr705, and the expression of TGF-β1, collagen IV and fibronectin in the cells. Treatment of the cells with Ang II (1 μmol/L) significantly increased STAT3 phosphorylation on Tyr705 through JAK2 activation, and dose-dependently increased the expression of fibronectin, collagen IV and TGF-β1. Pretreatment with curcumin, an inhibitor of JAK2 and p300, blocked Ang II-induced effects. Knockdown of p300 significantly decreased STAT3 acetylation on Lys685, and abolished Ang II-stimulated STAT3 phosphorylation on Tyr705, whereas pretreatment of the cells with C646, a selective inhibitor of p300, inhibited Ang II-induced STAT3 nuclear translocation and the expression of TGF-β1, collagen IV and fibronectin. Pretreatment of the cells with AG490, a JAK2 inhibitor, markedly inhibited Ang II-induced STAT3 phosphorylation on Tyr705 and fibronectin expression. Conclusion: p300-dependent STAT3 acetylation is necessary for Ang II-induced STAT3 phosphorylation and the consequent pro-fibrotic responses in renal tubular epithelial cells in vitro .
Author Jun NI Yang SHEN Zhen WANG De-cui SHAO Jia LIU Ya-li KONG Lan-jun FU Li ZHOU Hong XUE Yu HUANG Wei ZHANG Chen YU Li-min LU
AuthorAffiliation Department of Physiology and Pathophysiology, Shanghai Medical College, Fudan University, Shanghai 200032, China Departmentof Nephrology, Tongii Hospital, Tongii University School of Medicine, Shanghai 200065, China; 3School of Biomedical Sciences andInstitute of Vascular Medicine, Chinese University of Hong Kong, Hong Kong, China
Author_xml – sequence: 1
  givenname: Jun
  surname: Ni
  fullname: Ni, Jun
  organization: Department of Physiology and Pathophysiology, Shanghai Medical College, Fudan University
– sequence: 2
  givenname: Yang
  surname: Shen
  fullname: Shen, Yang
  organization: Department of Physiology and Pathophysiology, Shanghai Medical College, Fudan University
– sequence: 3
  givenname: Zhen
  surname: Wang
  fullname: Wang, Zhen
  organization: Department of Physiology and Pathophysiology, Shanghai Medical College, Fudan University
– sequence: 4
  givenname: De-cui
  surname: Shao
  fullname: Shao, De-cui
  organization: Department of Physiology and Pathophysiology, Shanghai Medical College, Fudan University
– sequence: 5
  givenname: Jia
  surname: Liu
  fullname: Liu, Jia
  organization: Department of Physiology and Pathophysiology, Shanghai Medical College, Fudan University
– sequence: 6
  givenname: Ya-li
  surname: Kong
  fullname: Kong, Ya-li
  organization: Department of Physiology and Pathophysiology, Shanghai Medical College, Fudan University
– sequence: 7
  givenname: Lan-jun
  surname: Fu
  fullname: Fu, Lan-jun
  organization: Department of Nephrology, Tongji Hospital, Tongji University School of Medicine
– sequence: 8
  givenname: Li
  surname: Zhou
  fullname: Zhou, Li
  organization: Department of Physiology and Pathophysiology, Shanghai Medical College, Fudan University
– sequence: 9
  givenname: Hong
  surname: Xue
  fullname: Xue, Hong
  organization: Department of Physiology and Pathophysiology, Shanghai Medical College, Fudan University
– sequence: 10
  givenname: Yu
  surname: Huang
  fullname: Huang, Yu
  organization: School of Biomedical Sciences and Institute of Vascular Medicine, Chinese University of Hong Kong
– sequence: 11
  givenname: Wei
  surname: Zhang
  fullname: Zhang, Wei
  organization: Department of Physiology and Pathophysiology, Shanghai Medical College, Fudan University
– sequence: 12
  givenname: Chen
  surname: Yu
  fullname: Yu, Chen
  email: yuchen2001@hotmail.com
  organization: Department of Nephrology, Tongji Hospital, Tongji University School of Medicine
– sequence: 13
  givenname: Li-min
  surname: Lu
  fullname: Lu, Li-min
  email: lulimin@shmu.edu.cn
  organization: Department of Physiology and Pathophysiology, Shanghai Medical College, Fudan University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25088002$$D View this record in MEDLINE/PubMed
BookMark eNptkttrFDEUxoNU7EWffJegL4LOmkwuk3kplOJloaDg-hyymTO7KbPJNMkIffQ_N-NuSy19Ssj5nY_vyzmn6MgHDwi9pmRBCVOfzJgWNaF8IfgzdEIbLqqmFvyo3GVDK04UO0anKV0TwmpG2xfouBZEKULqE_TnByOk6mAE34HP-OfqYsWwsZBvB5Nd8Ngl7MFCSibe4j5EbPzGhQw-OY-Xy8r5brLQ4TGGqnfrGLKzOEIag0-QcIEieDPgPK2nwUQMo8tbGFx5sjAM6SV63pshwavDeYZ-ffm8uvxWXX3_ury8uKqsYG2uGCXlbEVjTK-sEVT0khnoWwOGsxKsU0y2zEgrpeysKtWe9rVRlNK2big7Q-d73XFa76CzJW00gx6j25VkOhin_694t9Wb8FtzKoSomyLw_iAQw80EKeudS3ME4yFMSVMhCWmFakRB3z1Cr8MUyy_MlGgJUYLNjt48dHRv5W46BaB7wMaQUoReW5f_TaUYdIOmRM8boMsG6HkDtOCl58OjnjvZp-mPezoVym8gPjD6JP72IL4NfnNTOu7VpWSCKyIp-wt8fs0Y
CitedBy_id crossref_primary_10_1016_j_cellsig_2022_110407
crossref_primary_10_1016_j_ijbiomac_2023_128567
crossref_primary_10_1002_iub_2574
crossref_primary_10_1093_nar_gkw826
crossref_primary_10_18632_oncotarget_26110
crossref_primary_10_1016_j_taap_2015_11_011
crossref_primary_10_1155_2017_2418671
crossref_primary_10_1186_s11658_024_00590_w
crossref_primary_10_3389_fphar_2016_00126
crossref_primary_10_1016_j_kint_2017_03_006
crossref_primary_10_1038_s41698_021_00158_3
crossref_primary_10_1186_s12964_022_00870_y
crossref_primary_10_1016_j_ijcard_2016_11_204
crossref_primary_10_1016_j_apsb_2025_02_007
crossref_primary_10_1016_j_jnutbio_2022_109031
crossref_primary_10_1038_s41392_023_01379_7
crossref_primary_10_1038_aps_2016_12
crossref_primary_10_1155_2021_6673343
crossref_primary_10_1038_srep20481
crossref_primary_10_1111_ajt_14221
crossref_primary_10_1016_j_biopha_2023_115166
crossref_primary_10_1016_j_bbamcr_2015_10_019
crossref_primary_10_3389_fphar_2022_760308
crossref_primary_10_4049_jimmunol_2001178
crossref_primary_10_1111_jcmm_17447
crossref_primary_10_1161_ATVBAHA_118_311276
crossref_primary_10_4049_immunohorizons_2100112
crossref_primary_10_1038_s42003_024_07134_0
crossref_primary_10_1016_j_phymed_2018_09_182
crossref_primary_10_1111_bph_14686
crossref_primary_10_1038_s41419_019_1589_y
crossref_primary_10_3390_biomedicines12092102
Cites_doi 10.1038/aps.2012.18
10.1152/ajprenal.00620.2012
10.1126/science.1105166
10.1152/ajprenal.00477.2011
10.1038/aps.2012.164
10.1038/aps.2014.42
10.1152/ajpendo.00432.2009
10.1046/j.1523-1755.2003.00133.x
10.1038/379645a0
10.1152/ajprenal.00326.2007
10.1074/jbc.M413930200
10.1111/j.1440-1797.2007.00881.x
10.1016/j.regpep.2009.09.001
10.1681/ASN.2011050493
10.1161/HYPERTENSIONAHA.110.164244
10.1016/j.alcohol.2008.02.004
10.1038/emboj.2009.210
10.1016/0092-8674(95)90311-9
10.1096/fj.10-172288
10.1038/sj.ki.5000054
10.1016/j.chembiol.2010.03.006
10.1016/j.mce.2009.10.008
10.4049/jimmunol.171.11.6072
10.2337/db11-0478
10.1186/1476-4598-13-66
10.1007/s10549-012-2069-6
10.1053/j.gastro.2005.07.055
10.1046/j.1365-2141.2000.02127.x
10.1046/j.1523-1755.2002.00311.x
10.1172/JCI0215644
10.1038/aps.2014.16
10.2337/db06-0519
10.1161/01.RES.82.2.244
10.1152/ajprenal.00650.2012
10.1152/ajprenal.00282.2009
10.1038/jid.2013.187
10.1097/01.ASN.0000106015.29070.E7
10.1210/mend.16.4.0811
10.1593/neo.13478
10.1002/jcb.23135
10.1172/JCI0215518
10.1371/journal.pone.0055481
10.1186/1476-9255-7-19
10.1038/sj.onc.1203476
10.1093/ndt/gfs260
10.1253/circj.CJ-10-1072
10.1038/aps.2012.40
10.1007/s00395-012-0263-7
10.1002/ar.22820
10.1046/j.1523-1755.2002.00430.x
10.1016/j.urology.2009.02.059
10.2174/157340606776056133
10.1038/nm888
10.1038/cddis.2013.159
10.1074/jbc.M805941200
10.1053/j.ackd.2005.07.011
10.1016/j.nut.2008.12.007
ContentType Journal Article
Copyright CPS and SIMM 2014
Copyright Nature Publishing Group Sep 2014
Copyright © 2014 CPS and SIMM 2014 CPS and SIMM
Copyright_xml – notice: CPS and SIMM 2014
– notice: Copyright Nature Publishing Group Sep 2014
– notice: Copyright © 2014 CPS and SIMM 2014 CPS and SIMM
DBID 2RA
92L
CQIGP
W91
~WA
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QP
7QR
7T5
7TK
7TO
7U9
7X7
7XB
88E
8FD
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
LK8
M0S
M1P
M7N
M7P
P64
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7X8
5PM
DOI 10.1038/aps.2014.54
DatabaseName 维普期刊资源整合服务平台
中文科技期刊数据库-CALIS站点
中文科技期刊数据库-7.0平台
中文科技期刊数据库-医药卫生
中文科技期刊数据库- 镜像站点
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Immunology Abstracts
Neurosciences Abstracts
Oncogenes and Growth Factors Abstracts
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Algology Mycology and Protozoology Abstracts (Microbiology C)
Health & Medical Research Collection
Biological Science Collection
AIDS and Cancer Research Abstracts
Chemoreception Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Immunology Abstracts
Engineering Research Database
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE
ProQuest Central Student

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
DocumentTitleAlternate P300-dependent STAT3 acetylation is necessary for angiotensin II-induced pro-fibrotic responses in renal tubular epithelial cells
EISSN 1745-7254
EndPage 1166
ExternalDocumentID PMC4155527
3420527751
25088002
10_1038_aps_2014_54
663548061
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-05
-0E
-Q-
-S~
.3N
0R~
188
1OC
23M
2RA
2WC
31~
36B
3V.
4.4
406
53G
5GY
5VR
5VS
6J9
70F
7X7
8-1
88E
8FI
8FJ
8R4
8R5
8RM
92L
92M
9D9
9DE
A8Z
AADWK
AANZL
AATNV
AAWBL
AAYFA
AAYJO
AAZLF
ABAWZ
ABGIJ
ABKZE
ABUWG
ACAOD
ACBMV
ACBRV
ACBYP
ACGFO
ACGFS
ACIGE
ACIWK
ACKTT
ACPRK
ACRQY
ACTTH
ACVWB
ACXQS
ACZOJ
ADBBV
ADFRT
ADHDB
ADMDM
ADQMX
ADRAZ
ADYYL
AEDAW
AEFTE
AEJRE
AENEX
AESKC
AEVLU
AEXYK
AFBPY
AFKRA
AFNRJ
AFRAH
AFSHS
AFUIB
AFZJQ
AGAYW
AGEZK
AGGBP
AGHAI
AHMBA
AHSBF
AILAN
AJAOE
AJCLW
AJDOV
AJRNO
ALFFA
ALMA_UNASSIGNED_HOLDINGS
AMRJV
AMYLF
AOIJS
AXYYD
BAWUL
BBNVY
BENPR
BFHJK
BHPHI
BKKNO
BPHCQ
BVXVI
C1A
CAG
CAJEE
CAJUS
CCEZO
CCPQU
CHBEP
CIEJG
CO8
COF
CQIGP
CS3
CW9
DIK
DNIVK
DPUIP
E3Z
EBLON
EBS
EE.
EIOEI
EJD
EMB
EMOBN
ESTFP
F5P
FA0
FDQFY
FERAY
FIZPM
FSGXE
FYUFA
GX1
HCIFZ
HH5
HMCUK
HYE
HZI
HZ~
IWAJR
JSO
JUIAU
JZLTJ
K97
KQ8
LH4
LW6
M1P
M48
M7P
MK0
NQJWS
NXXTH
NYICJ
O9-
OK1
OVD
P2P
P6G
PQQKQ
PROAC
PSQYO
Q--
Q-4
Q2X
R-E
RNT
RNTTT
RPM
RT5
S..
SNX
SNYQT
SOHCF
SRMVM
SV3
SWTZT
T8U
TAOOD
TBHMF
TDRGL
TEORI
TR2
TSG
U1F
U1G
U5E
U5O
UKHRP
UZ5
W91
~88
~NG
~WA
-SE
AACDK
AASML
AAXDM
ABAKF
ABZZP
ACMJI
AEFQL
AEMSY
AFBBN
AGQEE
AIGIU
ALIPV
FIGPU
LGEZI
LOTEE
NADUK
ROL
AAYXX
ABBRH
ABDBE
ABFSG
ACMFV
ACSTC
AEZWR
AFDZB
AFHIU
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
SOJ
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7QR
7T5
7TK
7TO
7U9
7XB
8FD
8FE
8FH
8FK
ABRTQ
AZQEC
DWQXO
FR3
GNUQQ
H94
K9.
LK8
M7N
P64
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c539t-310539957aaf8ca515f63aef9aea43323d83693a6c666dc8f63f1f2a811192713
IEDL.DBID M48
ISSN 1671-4083
1745-7254
IngestDate Thu Aug 21 13:34:51 EDT 2025
Fri Jul 11 00:30:25 EDT 2025
Fri Jul 25 08:53:21 EDT 2025
Thu Apr 03 07:02:39 EDT 2025
Thu Apr 24 23:03:19 EDT 2025
Tue Jul 01 02:04:12 EDT 2025
Fri Feb 21 02:40:28 EST 2025
Wed Feb 14 10:36:00 EST 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords p300
AG490
angiotensin II
STAT3
C646
renal fibrosis
renal tubular epithelial cells
JAK2
extracellular matrix
curcumin
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c539t-310539957aaf8ca515f63aef9aea43323d83693a6c666dc8f63f1f2a811192713
Notes renal fibrosis; angiotensin II; renal tubular epithelial cells; STAT3; JAK2; extracellular matrix; p300; curcumin; C646; AG490
Aim: To explore the role of signal transducer and activator of transcription 3 (STAT3) signaling pathway, especially STAT3 acetylation, in angiotensin II (Ang II)-induced pro-fibrotic responses in renal tubular epithelial cells. Methods: Rat renal tubular epithelial cell line (NRK-52E) was used. STAT3 acetylation, phosphorylation and Janus kinase 2 (Jak2) phosphorylation, as well as the expression of fibronectin, collagen IV, transforming growth factor-131 (TGF-β1) and p300 were examined using Western blotting. The level and localization of STAT3 phosphorylation on Tyr705 were detected with fluorescence immunocytochemistry. The cells were transfected with a plasmid vector carrying p300 gene or siRNA targeting p300 to regulate p300 expression. Results: Overexpression of p300 significantly increased STAT3 acetylation on Lys685, STAT3 phosphorylation on Tyr705, and the expression of TGF-β1, collagen IV and fibronectin in the cells. Treatment of the cells with Ang II (1 pmol/L) significantly increased STAT3 phosphorylation on Tyr705 through JAK2 activation, and dose-dependently increased the expression of fibronectin, collagen IV and TGF-β1. Pretreatment with curcumin, an inhibitor of JAK2 and p300, blocked Ang II-induced effects. Knockdown of p300 significantly decreased STAT3 acetylation on Lys685, and abolished Ang II-stimulated STAT3 phosphorylation on Tyr705, whereas pretreatment of the cells with C646, a selective inhibitor of p300, inhibited Ang II-induced STAT3 nuclear translocation and the expression of TGF- 131, collagen IV and fibronectin. Pretreatment of the cells with AG490, a JAK2 inhibitor, markedly inhibited Ang II-induced STAT3 phosphorylation on Tyr705 and fibronectin expression. Conclusion: P300-dependent STAT3 acetylation is necessary for Ang II-induced STAT3 phosphorylation and the consequent pro-fibrotic responses in renal tubular epithelial cells in vitro.
31-1347/R
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://www.nature.com/articles/aps201454.pdf
PMID 25088002
PQID 1559008531
PQPubID 28815
PageCount 10
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4155527
proquest_miscellaneous_1560095875
proquest_journals_1559008531
pubmed_primary_25088002
crossref_citationtrail_10_1038_aps_2014_54
crossref_primary_10_1038_aps_2014_54
springer_journals_10_1038_aps_2014_54
chongqing_primary_663548061
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-09-01
PublicationDateYYYYMMDD 2014-09-01
PublicationDate_xml – month: 09
  year: 2014
  text: 2014-09-01
  day: 01
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: United States
– name: Shanghai
PublicationTitle Acta pharmacologica Sinica
PublicationTitleAbbrev Acta Pharmacol Sin
PublicationTitleAlternate Acta Pharmacologica Sinica
PublicationYear 2014
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References Schindler (CR15) 2002; 109
Chiu, Khan, Farhangkhoee, Chakrabarti (CR34) 2009; 25
Jain, Wei, Mitrani, Bishopric (CR39) 2012; 135
Liu (CR2) 2006; 69
Amiri, Shaw, Wang, Tang, Waller, Eaton (CR19) 2002; 61
Yan, Eller, Elm, Larocca, Ryu, Panova (CR52) 2013; 133
Meydan, Grunberger, Dadi, Shahar, Arpaia, Lapidot (CR53) 1996; 379
Wen, Zhong, Darnell (CR26) 1995; 82
Gao, Lin, Ning, Gao, Yao, Zhou (CR51) 2013; 8
Kodama, Fukuda, Pan, Makino, Sano, Takahashi (CR16) 1998; 82
Kandalam, Clark (CR18) 2010; 159
Bromberg, Darnell (CR21) 2000; 19
Kaur, Chen, Xin, Chiu, Khan, Chakrabarti (CR33) 2006; 55
Li, Li, Guo, Chu, Gao, Zhu (CR11) 2013; 34
Chen, Feng, George, Chakrabarti, Chen, Chakrabarti (CR35) 2010; 298
Qian, Wang, Yao, Wang, Xue, Liu (CR55) 2013; 296
Eddy (CR1) 2005; 12
Yuan Z, Guan Y, Chatterjee, Chin (CR28) 2005; 307
Scuto, Kirschbaum, Buettner, Kujawski, Cermak, Atadja (CR40) 2013; 4
Ivanova, Butt, Matsell (CR8) 2008; 294
Wang, Yang, Yang, Cang, Huang, Li (CR31) 2012; 33
He, Zhang, Shao, Xue, Zhou, Wang (CR44) 2010; 315
Ranganathan, Jayakumar, Ramesh (CR9) 2013; 304
Wang, Cherukuri, Luo (CR27) 2005; 280
Zhong, Guo, Chen, Wang, Schuster, Loibner (CR10) 2011; 57
Liu (CR5) 2004; 15
Guo, Li, Wang, Lei L, Yu, Chen (CR56) 2014; 35
Zeisberg, Hanai, Sugimoto, Mammoto, Charytan, Strutz (CR7) 2003; 9
Hendrayani, Al-Khalaf, Aboussekhra (CR49) 2013; 15
Grande, Perez-Barriocanal, Lopez-Novoa (CR13) 2010; 7
Marcu, Jung, Lee, Chung, Lee, Trepel (CR45) 2006; 2
Bowers, Yan, Mukherjee, Orry, Wang, Holbert (CR50) 2010; 17
De Vos, Jourdan, Tarte, Jasmin, Klein (CR54) 2000; 109
Uchida, Miyajima, Kikuchi, Kozakai, Kosaka, Ieda (CR12) 2009; 74
Iwano, Plieth, Danoff, Xue, Okada, Neilson (CR4) 2002; 110
Sethi, Chatterjee, Rajendran, Li, Shanmugam, Wong K (CR41) 2014; 13
Hou, Ray, Lee, Brasier (CR32) 2008; 283
Chen, Wang, Zhou, Wang, Feng (CR20) 2003; 64
Ni, Shen, Wang, Shao, Liu, Fu (CR43) 2014; 35
Sestito, Madonna, Scarponi, Cianfarani, Failla, Cavani (CR38) 2011; 25
Tang, Lai (CR14) 2012; 27
Ray, Sherman, Lu, Brasier (CR29) 2002; 16
Hua, Feng, Rezonzew, Chumley, Jaimes (CR37) 2012; 302
Kuratsune, Masaki, Hirai, Kiribayashi, Yokoyama, Arakawa (CR23) 2007; 12
Liu, Hu, Long, Qiu, Mei, Hu (CR22) 2012; 33
Kim, Park, Joe, Jou (CR47) 2003; 171
Liu, Guo, Pang, Tolbert, Ponnusamy, Gong (CR25) 2012; 23
Feng, Chen, Mcarthur, Wu, Sen, Ding (CR36) 2011; 60
Duan, Yang, Yan, Yu, Liu, Zhou (CR48) 2012; 107
Weng, Aroor, Shukla (CR17) 2008; 42
Pang, Ma, Liu, Ponnusamy, Zhao, Yan (CR42) 2011; 112
Sunagawa, Morimoto, Wada, Takaya, Katanasaka, Kawamura (CR46) 2011; 75
Matsui, Rhee, Hile, Zhang, Meldrum (CR3) 2013; 305
Huang, Han, Wang, Sun, Yan, Yeh (CR30) 2009; 28
Pang, Kothapally, Mao, Tolbert, Ponnusamy, Chin (CR24) 2009; 297
Rastaldi, Ferrario, Giardino, Dell'Antonio, Grillo, Grillo (CR6) 2002; 62
Ray, Boldogh, Brasier (CR57) 2005; 129
T Hou (BFaps201454_CR32) 2008; 283
R Wang (BFaps201454_CR27) 2005; 280
R Sestito (BFaps201454_CR38) 2011; 25
SC Tang (BFaps201454_CR14) 2012; 27
Y Liu (BFaps201454_CR2) 2006; 69
DB Liu (BFaps201454_CR22) 2012; 33
G Sethi (BFaps201454_CR41) 2014; 13
Y Sunagawa (BFaps201454_CR46) 2011; 75
YI Weng (BFaps201454_CR17) 2008; 42
Y Uchida (BFaps201454_CR12) 2009; 74
S Ray (BFaps201454_CR29) 2002; 16
F Matsui (BFaps201454_CR3) 2013; 305
N Liu (BFaps201454_CR25) 2012; 23
S Ray (BFaps201454_CR57) 2005; 129
MP Rastaldi (BFaps201454_CR6) 2002; 62
M Zeisberg (BFaps201454_CR7) 2003; 9
Y Wang (BFaps201454_CR31) 2012; 33
F Amiri (BFaps201454_CR19) 2002; 61
M Pang (BFaps201454_CR24) 2009; 297
L Ivanova (BFaps201454_CR8) 2008; 294
CW Schindler (BFaps201454_CR15) 2002; 109
S Jain (BFaps201454_CR39) 2012; 135
Y Liu (BFaps201454_CR5) 2004; 15
M Iwano (BFaps201454_CR4) 2002; 110
P Hua (BFaps201454_CR37) 2012; 302
J Ni (BFaps201454_CR43) 2014; 35
S Chen (BFaps201454_CR35) 2010; 298
U Kandalam (BFaps201454_CR18) 2010; 159
J Bromberg (BFaps201454_CR21) 2000; 19
J Zhong (BFaps201454_CR10) 2011; 57
MG Marcu (BFaps201454_CR45) 2006; 2
EM Bowers (BFaps201454_CR50) 2010; 17
MT Grande (BFaps201454_CR13) 2010; 7
N Meydan (BFaps201454_CR53) 1996; 379
XN Gao (BFaps201454_CR51) 2013; 8
YQ Li (BFaps201454_CR11) 2013; 34
C Huang (BFaps201454_CR30) 2009; 28
AA Eddy (BFaps201454_CR1) 2005; 12
C Qian (BFaps201454_CR55) 2013; 296
B Feng (BFaps201454_CR36) 2011; 60
HY Kim (BFaps201454_CR47) 2003; 171
J De Vos (BFaps201454_CR54) 2000; 109
W Duan (BFaps201454_CR48) 2012; 107
D Guo (BFaps201454_CR56) 2014; 35
L Yuan Z (BFaps201454_CR28) 2005; 307
M He (BFaps201454_CR44) 2010; 315
G Yan (BFaps201454_CR52) 2013; 133
A Scuto (BFaps201454_CR40) 2013; 4
H Kodama (BFaps201454_CR16) 1998; 82
P Ranganathan (BFaps201454_CR9) 2013; 304
SF Hendrayani (BFaps201454_CR49) 2013; 15
J Chiu (BFaps201454_CR34) 2009; 25
M Kuratsune (BFaps201454_CR23) 2007; 12
X Chen (BFaps201454_CR20) 2003; 64
H Kaur (BFaps201454_CR33) 2006; 55
M Pang (BFaps201454_CR42) 2011; 112
Z Wen (BFaps201454_CR26) 1995; 82
23698071 - J Invest Dermatol. 2013 Oct;133(10):2444-52
22562121 - Breast Cancer Res Treat. 2012 Aug;135(1):103-14
19268536 - Nutrition. 2009 Sep;25(9):964-72
19903865 - Am J Physiol Endocrinol Metab. 2010 Jan;298(1):E127-37
12808448 - Nat Med. 2003 Jul;9(7):964-8
16787365 - Med Chem. 2006 Mar;2(2):169-74
15653507 - Science. 2005 Jan 14;307(5707):269-73
24976155 - Acta Pharmacol Sin. 2014 Aug;35(8):1045-54
22466958 - Basic Res Cardiol. 2012 May;107(3):263
14634121 - J Immunol. 2003 Dec 1;171(11):6072-9
11994400 - J Clin Invest. 2002 May;109(9):1133-7
11967010 - Kidney Int. 2002 May;61(5):1605-16
14694152 - J Am Soc Nephrol. 2004 Jan;15(1):1-12
19428059 - Urology. 2009 Oct;74(4):938-43
19680224 - EMBO J. 2009 Sep 16;28(18):2748-62
7543024 - Cell. 1995 Jul 28;82(2):241-50
21189404 - Hypertension. 2011 Feb;57(2):314-22
10851045 - Oncogene. 2000 May 15;19(21):2468-73
24655440 - Mol Cancer. 2014;13:66
10929036 - Br J Haematol. 2000 Jun;109(4):823-8
22734110 - Nephrol Dial Transplant. 2012 Aug;27(8):3049-56
21465537 - J Cell Biochem. 2011 Aug;112(8):2138-48
20534345 - Chem Biol. 2010 May 28;17(5):471-82
23681230 - Cell Death Dis. 2013;4:e635
22357921 - Am J Physiol Renal Physiol. 2012 Jun 1;302(11):F1418-29
24151255 - Anat Rec (Hoboken). 2013 Dec;296(12):1865-73
19879325 - Mol Cell Endocrinol. 2010 Feb 5;315(1-2):188-94
20412564 - J Inflamm (Lond). 2010 Apr 22;7:19
11923478 - Mol Endocrinol. 2002 Apr;16(4):824-36
21737953 - Circ J. 2011;75(9):2151-9
12081572 - Kidney Int. 2002 Jul;62(1):137-46
15649887 - J Biol Chem. 2005 Mar 25;280(12):11528-34
22362908 - J Am Soc Nephrol. 2012 May;23(5):854-67
12846741 - Kidney Int. 2003 Aug;64(2):459-67
9468195 - Circ Res. 1998 Feb 9;82(2):244-50
23730211 - Neoplasia. 2013 Jun;15(6):631-40
19748527 - Regul Pept. 2010 Jan 8;159(1-3):110-6
23408169 - Am J Physiol Renal Physiol. 2013 Apr 15;304(8):F1054-65
21885871 - Diabetes. 2011 Nov;60(11):2975-84
22684029 - Acta Pharmacol Sin. 2012 Jul;33(7):953-63
12163453 - J Clin Invest. 2002 Aug;110(3):341-50
18782771 - J Biol Chem. 2008 Nov 7;283(45):30725-34
8628398 - Nature. 1996 Feb 15;379(6566):645-8
16408108 - Kidney Int. 2006 Jan;69(2):213-7
21098725 - FASEB J. 2011 Mar;25(3):916-27
18322023 - Am J Physiol Renal Physiol. 2008 May;294(5):F1238-48
22504904 - Acta Pharmacol Sin. 2012 May;33(5):682-90
23390536 - PLoS One. 2013;8(2):e55481
24747164 - Acta Pharmacol Sin. 2014 Jun;35(6):770-8
23904224 - Am J Physiol Renal Physiol. 2013 Oct 1;305(7):F1014-21
16285960 - Gastroenterology. 2005 Nov;129(5):1616-32
17065349 - Diabetes. 2006 Nov;55(11):3104-11
18411006 - Alcohol. 2008 Aug;42(5):397-406
23334241 - Acta Pharmacol Sin. 2013 Mar;34(3):352-9
19640900 - Am J Physiol Renal Physiol. 2009 Oct;297(4):F996-F1005
17995582 - Nephrology (Carlton). 2007 Dec;12(6):565-71
References_xml – volume: 33
  start-page: 682
  year: 2012
  end-page: 90
  ident: CR22
  article-title: Celecoxib induces apoptosis and cell-cycle arrest in nasopharyngeal carcinoma cell lines via inhibition of STAT3 phosphorylation
  publication-title: Acta Pharmacol Sin
  doi: 10.1038/aps.2012.18
– volume: 305
  start-page: F1014
  year: 2013
  end-page: F1021
  ident: CR3
  article-title: IL-18 induces profibrotic renal tubular cell injury via STAT3 activation
  publication-title: Am J Physiol Renal Physiol
  doi: 10.1152/ajprenal.00620.2012
– volume: 307
  start-page: 269
  year: 2005
  end-page: 73
  ident: CR28
  article-title: Stat3 dimerization regulated by reversible acetylation of a single lysine residue
  publication-title: Science
  doi: 10.1126/science.1105166
– volume: 302
  start-page: F1418
  year: 2012
  end-page: F1429
  ident: CR37
  article-title: The transcription factor ETS-1 regulates angiotensin II-stimulated fibronectin production in mesangial cells
  publication-title: Am J Physiol Renal Physiol
  doi: 10.1152/ajprenal.00477.2011
– volume: 34
  start-page: 352
  year: 2013
  end-page: 9
  ident: CR11
  article-title: Apocynin attenuates oxidative stress and cardiac fibrosis in angiotensin II-induced cardiac diastolic dysfunction in mice
  publication-title: Acta Pharmacol Sin
  doi: 10.1038/aps.2012.164
– volume: 35
  start-page: 1045
  year: 2014
  end-page: 54
  ident: CR43
  article-title: STAT3 acetylation is associated with angiotesin II-induced murine renal fibrosis
  publication-title: Acta Pharmacol Sin
  doi: 10.1038/aps.2014.42
– volume: 298
  start-page: E127
  year: 2010
  end-page: E137
  ident: CR35
  article-title: Transcriptional coactivator p300 regulates glucose-induced gene expression in endothelial cells
  publication-title: Am J Physiol Endocrinol Metab
  doi: 10.1152/ajpendo.00432.2009
– volume: 64
  start-page: 459
  year: 2003
  end-page: 67
  ident: CR20
  article-title: STAT proteins mediate angiotensin II-induced production of TIMP-1 in human proximal tubular epithelial cells
  publication-title: Kidney Int
  doi: 10.1046/j.1523-1755.2003.00133.x
– volume: 379
  start-page: 645
  year: 1996
  end-page: 8
  ident: CR53
  article-title: Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor
  publication-title: Nature
  doi: 10.1038/379645a0
– volume: 294
  start-page: F1238
  year: 2008
  end-page: F1248
  ident: CR8
  article-title: Mesenchymal transition in kidney collecting duct epithelial cells
  publication-title: Am J Physiol Renal Physiol
  doi: 10.1152/ajprenal.00326.2007
– volume: 280
  start-page: 11528
  year: 2005
  end-page: 34
  ident: CR27
  article-title: Activation of Stat3 sequence-specific DNA binding and transcription by p300/CREB-binding protein-mediated acetylation
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M413930200
– volume: 12
  start-page: 565
  year: 2007
  end-page: 71
  ident: CR23
  article-title: Signal transducer and activator of transcription 3 involvement in the development of renal interstitial fibrosis after unilateral ureteral obstruction
  publication-title: Nephrology (Carlton)
  doi: 10.1111/j.1440-1797.2007.00881.x
– volume: 159
  start-page: 110
  year: 2010
  end-page: 6
  ident: CR18
  article-title: Angiotensin II activates JAK2/STAT3 pathway and induces interleukin-6 production in cultured rat brainstem astrocytes
  publication-title: Regul Pept
  doi: 10.1016/j.regpep.2009.09.001
– volume: 23
  start-page: 854
  year: 2012
  end-page: 67
  ident: CR25
  article-title: Genetic or pharmacologic blockade of EGFR inhibits renal fibrosis
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2011050493
– volume: 57
  start-page: 314
  year: 2011
  end-page: 22
  ident: CR10
  article-title: Prevention of angiotensin II-mediated renal oxidative stress, inflammation, and fibrosis by angiotensin-converting enzyme 2
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.110.164244
– volume: 42
  start-page: 397
  year: 2008
  end-page: 406
  ident: CR17
  article-title: Ethanol inhibition of angiotensin II-stimulated Tyr705 and Ser727 STAT3 phosphorylation in cultured rat hepatocytes: relevance to activation of p42/44 mitogen-activated protein kinase
  publication-title: Alcohol
  doi: 10.1016/j.alcohol.2008.02.004
– volume: 28
  start-page: 2748
  year: 2009
  end-page: 62
  ident: CR30
  article-title: SENP3 is responsible for HIF-1 transactivation under mild oxidative stress via p300 de-SUMOylation
  publication-title: EMBO J
  doi: 10.1038/emboj.2009.210
– volume: 82
  start-page: 241
  year: 1995
  end-page: 50
  ident: CR26
  article-title: Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation
  publication-title: Cell
  doi: 10.1016/0092-8674(95)90311-9
– volume: 25
  start-page: 916
  year: 2011
  end-page: 27
  ident: CR38
  article-title: STAT3-dependent effects of IL-22 in human keratinocytes are counterregulated by sirtuin 1 through a direct inhibition of STAT3 acetylation
  publication-title: FASEB J
  doi: 10.1096/fj.10-172288
– volume: 69
  start-page: 213
  year: 2006
  end-page: 7
  ident: CR2
  article-title: Renal fibrosis: new insights into the pathogenesis and therapeutics
  publication-title: Kidney Int
  doi: 10.1038/sj.ki.5000054
– volume: 17
  start-page: 471
  year: 2010
  end-page: 82
  ident: CR50
  article-title: Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor
  publication-title: Chem Biol
  doi: 10.1016/j.chembiol.2010.03.006
– volume: 315
  start-page: 188
  year: 2010
  end-page: 94
  ident: CR44
  article-title: Angiotensin II type 2 receptor mediated angiotensin II and high glucose induced decrease in renal prorenin/renin receptor expression
  publication-title: Mol Cell Endocrinol
  doi: 10.1016/j.mce.2009.10.008
– volume: 171
  start-page: 6072
  year: 2003
  end-page: 9
  ident: CR47
  article-title: Curcumin suppresses Janus kinase-STAT inflammatory signaling through activation of Src homology 2 domain-containing tyrosine phosphatase 2 in brain microglia
  publication-title: J Immunol
  doi: 10.4049/jimmunol.171.11.6072
– volume: 60
  start-page: 2975
  year: 2011
  end-page: 84
  ident: CR36
  article-title: miR-146a-Mediated extracellular matrix protein production in chronic diabetes complications
  publication-title: Diabetes
  doi: 10.2337/db11-0478
– volume: 13
  start-page: 66
  year: 2014
  ident: CR41
  article-title: Inhibition of STAT3 dimerization and acetylation by garcinol suppresses the growth of human hepatocellular carcinoma and
  publication-title: Mol Cancer
  doi: 10.1186/1476-4598-13-66
– volume: 135
  start-page: 103
  year: 2012
  end-page: 14
  ident: CR39
  article-title: Auto-acetylation stabilizes p300 in cardiac myocytes during acute oxidative stress, promoting STAT3 accumulation and cell survival
  publication-title: Breast Cancer Res Treat
  doi: 10.1007/s10549-012-2069-6
– volume: 129
  start-page: 1616
  year: 2005
  end-page: 32
  ident: CR57
  article-title: STAT3 NH -terminal acetylation is activated by the hepatic acute-phase response and required for IL-6 induction of angiotensinogen
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2005.07.055
– volume: 109
  start-page: 823
  year: 2000
  end-page: 8
  ident: CR54
  article-title: JAK2 tyrosine kinase inhibitor tyrphostin AG490 downregulates the mitogen-activated protein kinase (MAPK) and signal transducer and activator of transcription (STAT) pathways and induces apoptosis in myeloma cells
  publication-title: Br J Haematol
  doi: 10.1046/j.1365-2141.2000.02127.x
– volume: 61
  start-page: 1605
  year: 2002
  end-page: 16
  ident: CR19
  article-title: Angiotensin II activation of the JAK/STAT pathway in mesangial cells is altered by high glucose
  publication-title: Kidney Int
  doi: 10.1046/j.1523-1755.2002.00311.x
– volume: 109
  start-page: 1133
  year: 2002
  end-page: 7
  ident: CR15
  article-title: Series introduction. JAK-STAT signaling in human disease
  publication-title: J Clin Invest
  doi: 10.1172/JCI0215644
– volume: 35
  start-page: 770
  year: 2014
  end-page: 8
  ident: CR56
  article-title: Cyclovirobuxinum D suppresses lipopolysaccharide-induced inflammatory responses in murine macrophages by blocking JAK-STAT signaling pathway
  publication-title: Acta Pharmacol Sin
  doi: 10.1038/aps.2014.16
– volume: 55
  start-page: 3104
  year: 2006
  end-page: 11
  ident: CR33
  article-title: Diabetes-induced extracellular matrix protein expression is mediated by transcription coactivator p300
  publication-title: Diabetes
  doi: 10.2337/db06-0519
– volume: 82
  start-page: 244
  year: 1998
  end-page: 50
  ident: CR16
  article-title: Biphasic activation of the JAK/STAT pathway by angiotensin II in rat cardiomyocytes
  publication-title: Circ Res
  doi: 10.1161/01.RES.82.2.244
– volume: 304
  start-page: F1054
  year: 2013
  end-page: F1065
  ident: CR9
  article-title: Proximal tubule-specific overexpression of netrin-1 suppresses acute kidney injury-induced interstitial fibrosis and glomerulosclerosis through suppression of IL-6/STAT3 signaling
  publication-title: Am J Physiol Renal Physiol
  doi: 10.1152/ajprenal.00650.2012
– volume: 297
  start-page: F996
  year: 2009
  end-page: F1005
  ident: CR24
  article-title: Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy
  publication-title: Am J Physiol Renal Physiol
  doi: 10.1152/ajprenal.00282.2009
– volume: 133
  start-page: 2444
  year: 2013
  end-page: 52
  ident: CR52
  article-title: Selective inhibition of p300 HAT blocks cell cycle progression, induces cellular senescence, and inhibits the DNA damage response in melanoma cells
  publication-title: J Invest Dermatol
  doi: 10.1038/jid.2013.187
– volume: 15
  start-page: 1
  year: 2004
  end-page: 12
  ident: CR5
  article-title: Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention
  publication-title: J Am Soc Nephrol
  doi: 10.1097/01.ASN.0000106015.29070.E7
– volume: 16
  start-page: 824
  year: 2002
  end-page: 36
  ident: CR29
  article-title: Angiotensinogen gene expression is dependent on signal transducer and activator of transcription 3-mediated p300/cAMP response element binding protein-binding protein coactivator recruitment and histone acetyltransferase activity
  publication-title: Mol Endocrinol
  doi: 10.1210/mend.16.4.0811
– volume: 15
  start-page: 631
  year: 2013
  end-page: 40
  ident: CR49
  article-title: Curcumin triggers p16-dependent senescence in active breast cancer-associated fibroblasts and suppresses their paracrine procarcinogenic effects
  publication-title: Neoplasia
  doi: 10.1593/neo.13478
– volume: 112
  start-page: 2138
  year: 2011
  end-page: 48
  ident: CR42
  article-title: Histone deacetylase 1/2 mediates proliferation of renal interstitial fibroblasts and expression of cell cycle proteins
  publication-title: J Cell Biochem
  doi: 10.1002/jcb.23135
– volume: 110
  start-page: 341
  year: 2002
  end-page: 50
  ident: CR4
  article-title: Evidence that fibroblasts derive from epithelium during tissue fibrosis
  publication-title: J Clin Invest
  doi: 10.1172/JCI0215518
– volume: 8
  start-page: e 55481
  year: 2013
  ident: CR51
  article-title: A histone acetyltransferase p300 inhibitor C646 induces cell cycle arrest and apoptosis selectively in AML1-ETO-positive AML cells
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0055481
– volume: 7
  start-page: 19
  year: 2010
  ident: CR13
  article-title: Role of inflammation in tubulo-interstitial damage associated to obstructive nephropathy
  publication-title: J Inflamm (Lond)
  doi: 10.1186/1476-9255-7-19
– volume: 19
  start-page: 2468
  year: 2000
  end-page: 73
  ident: CR21
  article-title: The role of STATs in transcriptional control and their impact on cellular function
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1203476
– volume: 27
  start-page: 3049
  year: 2012
  end-page: 56
  ident: CR14
  article-title: The pathogenic role of the renal proximal tubular cell in diabetic nephropathy
  publication-title: Nephrol Dial Transplant
  doi: 10.1093/ndt/gfs260
– volume: 75
  start-page: 2151
  year: 2011
  end-page: 9
  ident: CR46
  article-title: A natural p300-specific histone acetyltransferase inhibitor, curcumin, in addition to angiotensin-converting enzyme inhibitor, exerts beneficial effects on left ventricular systolic function after myocardial infarction in rats
  publication-title: Circ J
  doi: 10.1253/circj.CJ-10-1072
– volume: 33
  start-page: 953
  year: 2012
  end-page: 63
  ident: CR31
  article-title: The biphasic redox sensing of SENP3 accounts for the HIF-1 transcriptional activity shift by oxidative stress
  publication-title: Acta Pharmacol Sin
  doi: 10.1038/aps.2012.40
– volume: 107
  start-page: 263
  year: 2012
  ident: CR48
  article-title: The effects of curcumin post-treatment against myocardial ischemia and reperfusion by activation of the JAK2/STAT3 signaling pathway
  publication-title: Basic Res Cardiol
  doi: 10.1007/s00395-012-0263-7
– volume: 296
  start-page: 1865
  year: 2013
  end-page: 73
  ident: CR55
  article-title: Involvement of nuclear JAK2 signaling in AG490-induced apoptosis of gastric cancer cells
  publication-title: Anat Rec (Hoboken)
  doi: 10.1002/ar.22820
– volume: 62
  start-page: 137
  year: 2002
  end-page: 46
  ident: CR6
  article-title: Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies
  publication-title: Kidney Int
  doi: 10.1046/j.1523-1755.2002.00430.x
– volume: 74
  start-page: 938
  year: 2009
  end-page: 43
  ident: CR12
  article-title: Renal damage inhibited in mice lacking angiotensinogen gene subjected to unilateral ureteral obstruction
  publication-title: Urology
  doi: 10.1016/j.urology.2009.02.059
– volume: 2
  start-page: 169
  year: 2006
  end-page: 74
  ident: CR45
  article-title: Curcumin is an inhibitor of p300 histone acetylatransferase
  publication-title: Med Chem
  doi: 10.2174/157340606776056133
– volume: 9
  start-page: 964
  year: 2003
  end-page: 8
  ident: CR7
  article-title: BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury
  publication-title: Nat Med
  doi: 10.1038/nm888
– volume: 4
  start-page: e635
  year: 2013
  ident: CR40
  article-title: SIRT1 activation enhances HDAC inhibition-mediated upregulation of GADD45G by repressing the binding of NF-kappaB/STAT3 complex to its promoter in malignant lymphoid cells
  publication-title: Cell Death Dis
  doi: 10.1038/cddis.2013.159
– volume: 283
  start-page: 30725
  year: 2008
  end-page: 34
  ident: CR32
  article-title: The STAT3 NH -terminal domain stabilizes enhanceosome assembly by interacting with the p300 bromodomain
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M805941200
– volume: 12
  start-page: 353
  year: 2005
  end-page: 65
  ident: CR1
  article-title: The STAT3 NH -terminal domain stabilizes enhanceosome assembly by interacting with the p300 bromodomain
  publication-title: Adv Chronic Kidney Dis
  doi: 10.1053/j.ackd.2005.07.011
– volume: 25
  start-page: 964
  year: 2009
  end-page: 72
  ident: CR34
  article-title: Curcumin prevents diabetes-associated abnormalities in the kidneys by inhibiting p300 and nuclear factor-kappaB
  publication-title: Nutrition
  doi: 10.1016/j.nut.2008.12.007
– volume: 13
  start-page: 66
  year: 2014
  ident: BFaps201454_CR41
  publication-title: Mol Cancer
  doi: 10.1186/1476-4598-13-66
– volume: 8
  start-page: e 55481
  year: 2013
  ident: BFaps201454_CR51
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0055481
– volume: 112
  start-page: 2138
  year: 2011
  ident: BFaps201454_CR42
  publication-title: J Cell Biochem
  doi: 10.1002/jcb.23135
– volume: 315
  start-page: 188
  year: 2010
  ident: BFaps201454_CR44
  publication-title: Mol Cell Endocrinol
  doi: 10.1016/j.mce.2009.10.008
– volume: 57
  start-page: 314
  year: 2011
  ident: BFaps201454_CR10
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.110.164244
– volume: 16
  start-page: 824
  year: 2002
  ident: BFaps201454_CR29
  publication-title: Mol Endocrinol
  doi: 10.1210/mend.16.4.0811
– volume: 109
  start-page: 823
  year: 2000
  ident: BFaps201454_CR54
  publication-title: Br J Haematol
  doi: 10.1046/j.1365-2141.2000.02127.x
– volume: 15
  start-page: 631
  year: 2013
  ident: BFaps201454_CR49
  publication-title: Neoplasia
  doi: 10.1593/neo.13478
– volume: 12
  start-page: 353
  year: 2005
  ident: BFaps201454_CR1
  publication-title: Adv Chronic Kidney Dis
  doi: 10.1053/j.ackd.2005.07.011
– volume: 379
  start-page: 645
  year: 1996
  ident: BFaps201454_CR53
  publication-title: Nature
  doi: 10.1038/379645a0
– volume: 133
  start-page: 2444
  year: 2013
  ident: BFaps201454_CR52
  publication-title: J Invest Dermatol
  doi: 10.1038/jid.2013.187
– volume: 82
  start-page: 241
  year: 1995
  ident: BFaps201454_CR26
  publication-title: Cell
  doi: 10.1016/0092-8674(95)90311-9
– volume: 4
  start-page: e635
  year: 2013
  ident: BFaps201454_CR40
  publication-title: Cell Death Dis
  doi: 10.1038/cddis.2013.159
– volume: 61
  start-page: 1605
  year: 2002
  ident: BFaps201454_CR19
  publication-title: Kidney Int
  doi: 10.1046/j.1523-1755.2002.00311.x
– volume: 296
  start-page: 1865
  year: 2013
  ident: BFaps201454_CR55
  publication-title: Anat Rec (Hoboken)
  doi: 10.1002/ar.22820
– volume: 42
  start-page: 397
  year: 2008
  ident: BFaps201454_CR17
  publication-title: Alcohol
  doi: 10.1016/j.alcohol.2008.02.004
– volume: 64
  start-page: 459
  year: 2003
  ident: BFaps201454_CR20
  publication-title: Kidney Int
  doi: 10.1046/j.1523-1755.2003.00133.x
– volume: 27
  start-page: 3049
  year: 2012
  ident: BFaps201454_CR14
  publication-title: Nephrol Dial Transplant
  doi: 10.1093/ndt/gfs260
– volume: 33
  start-page: 682
  year: 2012
  ident: BFaps201454_CR22
  publication-title: Acta Pharmacol Sin
  doi: 10.1038/aps.2012.18
– volume: 25
  start-page: 964
  year: 2009
  ident: BFaps201454_CR34
  publication-title: Nutrition
  doi: 10.1016/j.nut.2008.12.007
– volume: 2
  start-page: 169
  year: 2006
  ident: BFaps201454_CR45
  publication-title: Med Chem
  doi: 10.2174/157340606776056133
– volume: 35
  start-page: 770
  year: 2014
  ident: BFaps201454_CR56
  publication-title: Acta Pharmacol Sin
  doi: 10.1038/aps.2014.16
– volume: 7
  start-page: 19
  year: 2010
  ident: BFaps201454_CR13
  publication-title: J Inflamm (Lond)
  doi: 10.1186/1476-9255-7-19
– volume: 110
  start-page: 341
  year: 2002
  ident: BFaps201454_CR4
  publication-title: J Clin Invest
  doi: 10.1172/JCI0215518
– volume: 17
  start-page: 471
  year: 2010
  ident: BFaps201454_CR50
  publication-title: Chem Biol
  doi: 10.1016/j.chembiol.2010.03.006
– volume: 55
  start-page: 3104
  year: 2006
  ident: BFaps201454_CR33
  publication-title: Diabetes
  doi: 10.2337/db06-0519
– volume: 129
  start-page: 1616
  year: 2005
  ident: BFaps201454_CR57
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2005.07.055
– volume: 69
  start-page: 213
  year: 2006
  ident: BFaps201454_CR2
  publication-title: Kidney Int
  doi: 10.1038/sj.ki.5000054
– volume: 75
  start-page: 2151
  year: 2011
  ident: BFaps201454_CR46
  publication-title: Circ J
  doi: 10.1253/circj.CJ-10-1072
– volume: 304
  start-page: F1054
  year: 2013
  ident: BFaps201454_CR9
  publication-title: Am J Physiol Renal Physiol
  doi: 10.1152/ajprenal.00650.2012
– volume: 82
  start-page: 244
  year: 1998
  ident: BFaps201454_CR16
  publication-title: Circ Res
  doi: 10.1161/01.RES.82.2.244
– volume: 307
  start-page: 269
  year: 2005
  ident: BFaps201454_CR28
  publication-title: Science
  doi: 10.1126/science.1105166
– volume: 305
  start-page: F1014
  year: 2013
  ident: BFaps201454_CR3
  publication-title: Am J Physiol Renal Physiol
  doi: 10.1152/ajprenal.00620.2012
– volume: 107
  start-page: 263
  year: 2012
  ident: BFaps201454_CR48
  publication-title: Basic Res Cardiol
  doi: 10.1007/s00395-012-0263-7
– volume: 302
  start-page: F1418
  year: 2012
  ident: BFaps201454_CR37
  publication-title: Am J Physiol Renal Physiol
  doi: 10.1152/ajprenal.00477.2011
– volume: 35
  start-page: 1045
  year: 2014
  ident: BFaps201454_CR43
  publication-title: Acta Pharmacol Sin
  doi: 10.1038/aps.2014.42
– volume: 74
  start-page: 938
  year: 2009
  ident: BFaps201454_CR12
  publication-title: Urology
  doi: 10.1016/j.urology.2009.02.059
– volume: 25
  start-page: 916
  year: 2011
  ident: BFaps201454_CR38
  publication-title: FASEB J
  doi: 10.1096/fj.10-172288
– volume: 280
  start-page: 11528
  year: 2005
  ident: BFaps201454_CR27
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M413930200
– volume: 298
  start-page: E127
  year: 2010
  ident: BFaps201454_CR35
  publication-title: Am J Physiol Endocrinol Metab
  doi: 10.1152/ajpendo.00432.2009
– volume: 297
  start-page: F996
  year: 2009
  ident: BFaps201454_CR24
  publication-title: Am J Physiol Renal Physiol
  doi: 10.1152/ajprenal.00282.2009
– volume: 12
  start-page: 565
  year: 2007
  ident: BFaps201454_CR23
  publication-title: Nephrology (Carlton)
  doi: 10.1111/j.1440-1797.2007.00881.x
– volume: 15
  start-page: 1
  year: 2004
  ident: BFaps201454_CR5
  publication-title: J Am Soc Nephrol
  doi: 10.1097/01.ASN.0000106015.29070.E7
– volume: 109
  start-page: 1133
  year: 2002
  ident: BFaps201454_CR15
  publication-title: J Clin Invest
  doi: 10.1172/JCI0215644
– volume: 171
  start-page: 6072
  year: 2003
  ident: BFaps201454_CR47
  publication-title: J Immunol
  doi: 10.4049/jimmunol.171.11.6072
– volume: 294
  start-page: F1238
  year: 2008
  ident: BFaps201454_CR8
  publication-title: Am J Physiol Renal Physiol
  doi: 10.1152/ajprenal.00326.2007
– volume: 23
  start-page: 854
  year: 2012
  ident: BFaps201454_CR25
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2011050493
– volume: 9
  start-page: 964
  year: 2003
  ident: BFaps201454_CR7
  publication-title: Nat Med
  doi: 10.1038/nm888
– volume: 283
  start-page: 30725
  year: 2008
  ident: BFaps201454_CR32
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M805941200
– volume: 62
  start-page: 137
  year: 2002
  ident: BFaps201454_CR6
  publication-title: Kidney Int
  doi: 10.1046/j.1523-1755.2002.00430.x
– volume: 159
  start-page: 110
  year: 2010
  ident: BFaps201454_CR18
  publication-title: Regul Pept
  doi: 10.1016/j.regpep.2009.09.001
– volume: 33
  start-page: 953
  year: 2012
  ident: BFaps201454_CR31
  publication-title: Acta Pharmacol Sin
  doi: 10.1038/aps.2012.40
– volume: 28
  start-page: 2748
  year: 2009
  ident: BFaps201454_CR30
  publication-title: EMBO J
  doi: 10.1038/emboj.2009.210
– volume: 135
  start-page: 103
  year: 2012
  ident: BFaps201454_CR39
  publication-title: Breast Cancer Res Treat
  doi: 10.1007/s10549-012-2069-6
– volume: 19
  start-page: 2468
  year: 2000
  ident: BFaps201454_CR21
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1203476
– volume: 60
  start-page: 2975
  year: 2011
  ident: BFaps201454_CR36
  publication-title: Diabetes
  doi: 10.2337/db11-0478
– volume: 34
  start-page: 352
  year: 2013
  ident: BFaps201454_CR11
  publication-title: Acta Pharmacol Sin
  doi: 10.1038/aps.2012.164
– reference: 14634121 - J Immunol. 2003 Dec 1;171(11):6072-9
– reference: 17065349 - Diabetes. 2006 Nov;55(11):3104-11
– reference: 19640900 - Am J Physiol Renal Physiol. 2009 Oct;297(4):F996-F1005
– reference: 18782771 - J Biol Chem. 2008 Nov 7;283(45):30725-34
– reference: 11994400 - J Clin Invest. 2002 May;109(9):1133-7
– reference: 21189404 - Hypertension. 2011 Feb;57(2):314-22
– reference: 16408108 - Kidney Int. 2006 Jan;69(2):213-7
– reference: 24976155 - Acta Pharmacol Sin. 2014 Aug;35(8):1045-54
– reference: 18322023 - Am J Physiol Renal Physiol. 2008 May;294(5):F1238-48
– reference: 7543024 - Cell. 1995 Jul 28;82(2):241-50
– reference: 10851045 - Oncogene. 2000 May 15;19(21):2468-73
– reference: 21737953 - Circ J. 2011;75(9):2151-9
– reference: 23730211 - Neoplasia. 2013 Jun;15(6):631-40
– reference: 22734110 - Nephrol Dial Transplant. 2012 Aug;27(8):3049-56
– reference: 11967010 - Kidney Int. 2002 May;61(5):1605-16
– reference: 16787365 - Med Chem. 2006 Mar;2(2):169-74
– reference: 20534345 - Chem Biol. 2010 May 28;17(5):471-82
– reference: 14694152 - J Am Soc Nephrol. 2004 Jan;15(1):1-12
– reference: 21885871 - Diabetes. 2011 Nov;60(11):2975-84
– reference: 11923478 - Mol Endocrinol. 2002 Apr;16(4):824-36
– reference: 24655440 - Mol Cancer. 2014;13:66
– reference: 23681230 - Cell Death Dis. 2013;4:e635
– reference: 23334241 - Acta Pharmacol Sin. 2013 Mar;34(3):352-9
– reference: 21098725 - FASEB J. 2011 Mar;25(3):916-27
– reference: 15653507 - Science. 2005 Jan 14;307(5707):269-73
– reference: 9468195 - Circ Res. 1998 Feb 9;82(2):244-50
– reference: 23390536 - PLoS One. 2013;8(2):e55481
– reference: 19879325 - Mol Cell Endocrinol. 2010 Feb 5;315(1-2):188-94
– reference: 19680224 - EMBO J. 2009 Sep 16;28(18):2748-62
– reference: 19748527 - Regul Pept. 2010 Jan 8;159(1-3):110-6
– reference: 22562121 - Breast Cancer Res Treat. 2012 Aug;135(1):103-14
– reference: 21465537 - J Cell Biochem. 2011 Aug;112(8):2138-48
– reference: 15649887 - J Biol Chem. 2005 Mar 25;280(12):11528-34
– reference: 12081572 - Kidney Int. 2002 Jul;62(1):137-46
– reference: 12808448 - Nat Med. 2003 Jul;9(7):964-8
– reference: 19903865 - Am J Physiol Endocrinol Metab. 2010 Jan;298(1):E127-37
– reference: 12163453 - J Clin Invest. 2002 Aug;110(3):341-50
– reference: 22357921 - Am J Physiol Renal Physiol. 2012 Jun 1;302(11):F1418-29
– reference: 12846741 - Kidney Int. 2003 Aug;64(2):459-67
– reference: 19268536 - Nutrition. 2009 Sep;25(9):964-72
– reference: 10929036 - Br J Haematol. 2000 Jun;109(4):823-8
– reference: 8628398 - Nature. 1996 Feb 15;379(6566):645-8
– reference: 17995582 - Nephrology (Carlton). 2007 Dec;12(6):565-71
– reference: 24747164 - Acta Pharmacol Sin. 2014 Jun;35(6):770-8
– reference: 23904224 - Am J Physiol Renal Physiol. 2013 Oct 1;305(7):F1014-21
– reference: 18411006 - Alcohol. 2008 Aug;42(5):397-406
– reference: 23698071 - J Invest Dermatol. 2013 Oct;133(10):2444-52
– reference: 22362908 - J Am Soc Nephrol. 2012 May;23(5):854-67
– reference: 22504904 - Acta Pharmacol Sin. 2012 May;33(5):682-90
– reference: 22684029 - Acta Pharmacol Sin. 2012 Jul;33(7):953-63
– reference: 22466958 - Basic Res Cardiol. 2012 May;107(3):263
– reference: 23408169 - Am J Physiol Renal Physiol. 2013 Apr 15;304(8):F1054-65
– reference: 16285960 - Gastroenterology. 2005 Nov;129(5):1616-32
– reference: 19428059 - Urology. 2009 Oct;74(4):938-43
– reference: 24151255 - Anat Rec (Hoboken). 2013 Dec;296(12):1865-73
– reference: 20412564 - J Inflamm (Lond). 2010 Apr 22;7:19
SSID ssj0032319
Score 2.2525697
Snippet Aim: To explore the role of signal transducer and activator of transcription 3 (STAT3) signaling pathway, especially STAT3 acetylation, in angiotensin II (Ang...
Aim: To explore the signal transducer and activator of transcription 3 (STAT3) signaling pathway, especially STAT3 acetylation, in angiotensin II (Ang...
To explore the signal transducer and activator of transcription 3 (STAT3) signaling pathway, especially STAT3 acetylation, in angiotensin II (Ang II)-induced...
SourceID pubmedcentral
proquest
pubmed
crossref
springer
chongqing
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1157
SubjectTerms Acetylation - drug effects
Angiotensin II - pharmacology
Animals
Biomedical and Life Sciences
Biomedicine
Cell Line
E1A-Associated p300 Protein - metabolism
Epithelial Cells - drug effects
Epithelial Cells - metabolism
Fibrosis - chemically induced
Fibrosis - metabolism
Immunology
Internal Medicine
Kidney Tubules - drug effects
Kidney Tubules - metabolism
Medical Microbiology
Original
original-article
P300
Pharmacology/Toxicology
Rats
STAT3
STAT3 Transcription Factor - metabolism
Vaccine
乙酰化
依赖性
纤维化
肾小管上皮细胞
血管紧张素II
诱导作用
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB5BOcAFlXdoQUYqPaCGJnGcOCdUIaoWCbQSW2lvkePY7UqVs91kD3vkn3cmr2VZxNmTxMmM7W8yM98AHInAhkJa44dKKD-2QeArUSS-4aUNbRkVRUYFzj9-JhdX8feZmPU_3Oo-rXLYE9uNuqw0_SM_pfAZ4QMeflnc-dQ1iqKrfQuNh_CIqMsopSudjQ4XR-xC8DdMUvKTJO_r8wIuT9WCuLrD-DP1AXiMO427vsOzYvt02oGcu5mTf4VP21PpfB-e9nCSnXX6fwYPjHsOx5OOj3p9wqab8qr6hB2zyYapev0Cfk84frWhD27Dfk3PppwpbZp1lyLH5jVzhioJ1HLNEN8y5a7nVZv17tjlpY8ePdpGyfAdfIued4UPYssu79bUDIWWhibYrArKd2VmQTUgt2j0jEIG9Uu4Ov82_Xrh9z0ZfC141uCWHRCXrUiVslIrREM24crYTBlFVGi8lDzJuEo0-kWlljiKOo-UxD01i9AjfgV7rnLmDTC8skQNpYpnNtahUIh9TKSjEi_nUmsPDka95IuOeyMngBRLBCEefBo0leuezpy6atzmbVidyxxVnJOKcxF7cDQKD3f6p9jhoPK8X8p1vjE8Dz6Mw7gI6TMpZ6oVySSEVdH38-B1ZyHjcyKCwHjueJBu2c4oQATf2yNuftMSfRPYE1HqwcfByv6Y1u703_5_-gfwhAS7BLlD2GuWK_MOEVVTvG-XzT1w7SI9
  priority: 102
  providerName: ProQuest
Title P300-dependent STAT3 acetylation is necessary for angiotensin II-induced pro-fibrotic responses in renal tubular epithelial cells
URI http://lib.cqvip.com/qk/95561A/201409/663548061.html
https://link.springer.com/article/10.1038/aps.2014.54
https://www.ncbi.nlm.nih.gov/pubmed/25088002
https://www.proquest.com/docview/1559008531
https://www.proquest.com/docview/1560095875
https://pubmed.ncbi.nlm.nih.gov/PMC4155527
Volume 35
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1La9tAEB7yuPRS-q6S1GwhzaFEqaXV6nEoxS4xSSHGtDb4JtarVWIwkiPJUB37zzujV-o4h5502FntamdW8w3zAjgV_dgSfqxNSwppOnG_b0qxcE3No9iKI3uxCCjB-WbsXs2cH3Mx34O2GWdzgPmTph31k5plq4vf9-U3vPBf65Rx_4tcU91ty7kQzj4cokry6IbeOJ07gSOICerMSOrdKpwmUe_RZCqvcJcmt_eoNLbV1A723A2hfORHrdTT6AU8b3AlG9SC8BL2dPIKziZ1YerynE0f8qzyc3bGJg8lq8vX8GfC8fjahrgF-zUdTDmTShdlHSvHljlLNKUUyKxkCHSZTG6XaRX-nrDraxNNexSSiOE3mDGa4CkuxLI6AFfnDIkyTRssNgsKfGV6TckgK5R-Rr6D_A3MRpfT71dm05zBVIIHBf67-1TUVnhSxr6SCItil0sdB1JLqonGI5-7AZeuQgMpUj6OIvNt6ePPNbDRNH4LB0ma6PfAcGaEHPIkD2JHWUIiCNK2siOczn2lDDju-BKu6yIcISElx0c0YsDnllOhauqaU3uNVVj517kfIotDYnEoHANOO-L2TU-SnbQsD1uRDMmBSwiV45Ifu2G8jXRMMtHphmhcAq1oBBrwrpaQbh2bsDAqIAO8LdnpCKjS9_ZIsryrKn4T6hO2Z8CnVsr-2dbu9o_-Y3_H8Iyo63C5Ezgoso3-gPiqWPRg35t7PTgcjIbDMT6Hl-PJz151o_4Cn_0qfQ
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6V9FAuiDemBRap7QHV1Pb6eUCoQKuEtlEErtSbWa_XJVJlp7Ej5CN_iN_IjF8hBHHreWftTWZ25hvPC2DXMVLT8VOlm8IRup0ahi6c2NUVT1IzTaw4DqjA-XzsDi_sz5fO5Qb86mphKK2y04m1ok5ySd_IDyl8RviAm-9nNzpNjaLoajdCoxGLU1X9QJeteDf6hPzds6yT4_DjUG-nCujS4UGJSsegbqyOJ0TqS4H2PHW5UGkglKBmXjzxuRtw4UpE9on0cRVPbQkftUJgoU-Hz70DmzZHV2YAmx-Ox5Mvne7H3fUoEdP1yDPzeVsRaHD_UMyoO7hpv6XJA1uo27KrG7ROq_ZwDeSu52r-FbCt7eDJfbjXAlh21EjcA9hQ2UPYnzQdsKsDFi4LuooDts8my97Y1SP4OeHIp27ybsm-hkchZ0KqsmqS8ti0YJmi2gUxrxgiaiayq2le59lnbDTSp1mC0pgw_A16ir5-ji9i8ybTVxUMieaKDlguYsqwZWpGVSfXeM0YBSmKx3BxK_x6AoMsz9QzYLgzQQ55ggepLU1HINpSlrQS3M59KTXY7vkSzZpuHxFBMttH2KPBm45TkWwbqNMcj-uoDuRzP0IWR8TiyLE12O2Juyf9k2ynY3nUKo8iWoq6Bq_7Zbz29DeJTOULonEJHaO3qcHTRkL691gEutHSaeCtyE5PQC3FV1ey6fe6tTjBS8fyNNjrpOyPY60f__n_j_8Ktobh-Vl0NhqfbsNd2tSk5-3AoJwv1AvEc2X8sr1EDL7d9r39DbvjXzo
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VIgEXxBvTAovU9oBqEnu9fhwQqihRQ6GKRCrl5m7WuyVSZaexI-Qjf4tfx4xfIQRx63ln7XXmsd9kXgB7om8cERptO1JI2zP9vi3F1Lc1T4xjEnc6jajA-euZf3LufZ6IyRb8amthKK2ytYmVoU4yRf-R9yh8RviAOz3TpEWMjgcf5tc2TZCiSGs7TqMWkVNd_kD3LX8_PEZe77vu4NP444ndTBiwleBRgQaoT51ZRSClCZXEu934XGoTSS2psRdPQu5HXPoKUX6iQlzFL3BliBYictG_w-fegtsBFw7pWDDpnD3cWw0VcfyAfLSQN7WBfR725Jz6hDveO5pBcBetXHp5jffU-s24AXc3szb_Ct1WN-LgAdxvoCw7qmXvIWzp9BEcjOpe2OUhG69Ku_JDdsBGqy7Z5WP4OeLIsXYGb8G-jY_GnEmli7JOz2OznKWaqhjkomSIrZlML2dZlXGfsuHQnqUJymXC8Btsg15_hi9iizrnV-cMiRaaDlgsp5Rry_Sc6k-uUOEYhSvyJ3B-I9x6CttplurnwHBnghwKJI-MpxwhEXdpV7kJbuehUhbsdHyJ53Xfj5jAmRciALLgbcupWDWt1Gmix1VchfR5GCOLY2JxLDwL9jri9kn_JNttWR43ZiSPV0JvwZtuGQ0A_Uwy1dmSaHzCyeh3WvCslpDuPS7Bb7zzLAjWZKcjoObi6yvp7HvVZJyApnADC_ZbKfvjWJvHf_H_47-GO6it8Zfh2ekO3KM9dZ7eLmwXi6V-icCumL6qNIjBxU2r7G8YxWIK
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=P300-dependent+STAT3+acetylation+is+necessary+for+angiotensin+II-induced+pro-fibrotic+responses+in+renal+tubular+epithelial+cells&rft.jtitle=Acta+pharmacologica+Sinica&rft.au=Ni%2C+Jun&rft.au=Shen%2C+Yang&rft.au=Wang%2C+Zhen&rft.au=Shao%2C+De-cui&rft.date=2014-09-01&rft.issn=1745-7254&rft.eissn=1745-7254&rft.volume=35&rft.issue=9&rft.spage=1157&rft_id=info:doi/10.1038%2Faps.2014.54&rft.externalDBID=NO_FULL_TEXT
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F95561A%2F95561A.jpg